Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis

Immunity(2020)10.1016/j.immuni.2020.11.001Source: DataRank Database

Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis is a research paper published in Immunity (2020). On theSindex it has a DataRank of 0. It has been cited 87 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access87 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: hybridTopics (43)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Ayesha Dhillon-LaBrooy ORCID,Carla N. Castro ORCID,Nigatu Adossa ORCID,Guilhermina M. Carriche,Melanie Guderian

Live enrichment

PubMed:26207759

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

European Commission

Grant: 675395

European Network linking informatics and genomics of helper T cells

National Institutes of Health

Grant: 5R01HL056067-21

T-Cell Targeting for GVHD

European Commission

Grant: 647888

Molecular mechanisms of induced protection against sepsis by DNA damage responses

National Institutes of Health

Grant: 4R37AI034495-30

In Vivo Prevention of Murine GVHD

hybridLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S1074761320304660/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1074761320304660?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761320304660?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7837214

repositoryhttps://biblio.ugent.be/publication/8697692

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisINHIBITIONT cellsAutoimmunityOXAZOLIDINONEta3111ARGYRINPeptides, Cyclicmitochondrial translationArticleOxidative PhosphorylationantibioticsACTIVATIONMitochondrial ProteinsMiceNAD+ribosome-targetingMedicine and Health SciencesAnimalsHumanselongation factor G1TRANSCRIPTION FACTORMolecular Targeted TherapyMice, KnockoutLinezolidBiology and Life SciencesPATHWAYSCell DifferentiationDNANADPeptide Elongation Factor GAnti-Bacterial AgentsMitochondriaMice, Inbred C57BLRESPIRATIONTh17 CellsCHLORAMPHENICOLMEMBRANEDewey Decimal Classification::600 | Technik::610 | Medizin, GesundheitRibosomes

Sustainable Development Goals

SDG 3: 3. Good health